TreeWAS – Variant ID: rs12644284

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T31.0 Burns involving less than 10% of body surface	0.084	0.916	0.000
K74.3 Primary biliary cirrhosis	0.000	0.936	0.064
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.941	0.059
T31 Burns classified according to extent of body surface involved	0.052	0.948	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.956	0.044
T31.1 Burns involving 10-19% of body surface	0.040	0.960	0.000
K74.5 Biliary cirrhosis, unspecified	0.000	0.962	0.038
T31.9 Burns involving 90% or more of body surface	0.037	0.963	0.000
T31.8 Burns involving 80-89% of body surface	0.037	0.963	0.000
T31.7 Burns involving 70-79% of body surface	0.037	0.963	0.000
T31.6 Burns involving 60-69% of body surface	0.037	0.963	0.000
T31.5 Burns involving 50-59% of body surface	0.037	0.963	0.000
T31.4 Burns involving 40-49% of body surface	0.037	0.963	0.000
T31.3 Burns involving 30-39% of body surface	0.037	0.963	0.000
T31.2 Burns involving 20-29% of body surface	0.037	0.963	0.000
K74.0 Hepatic fibrosis	0.000	0.965	0.035
K74.4 Secondary biliary cirrhosis	0.000	0.968	0.032
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.968	0.032
K74.1 Hepatic sclerosis	0.000	0.968	0.032
K74.6 Other and unspecified cirrhosis of liver	0.000	0.970	0.030
T29-T32 Burns and corrosions of multiple and unspecified body regions	0.023	0.977	0.000
T29 Burns and corrosions of multiple body regions	0.017	0.983	0.000
T32 Corrosions classified according to extent of body surface involved	0.016	0.983	0.000
T30 Burn and corrosion, body region unspecified	0.016	0.983	0.000
U80.1 Methicillin resistant agent	0.000	0.985	0.015
K75.9 Inflammatory liver disease, unspecified	0.000	0.985	0.015
T29.3 Burns of multiple regions, at least one burn of third degree mentioned	0.013	0.987	0.000
K70-K77 Diseases of liver	0.000	0.987	0.013
K75 Other inflammatory liver diseases	0.000	0.987	0.013
T29.7 Corrosions of multiple regions, at least one corrosion of third degree mentioned	0.012	0.987	0.000
T29.6 Corrosions of multiple regions, no more than second-degree corrosions mentioned	0.012	0.987	0.000
T29.5 Corrosions of multiple regions, no more than first-degree corrosions mentioned	0.012	0.987	0.000
T29.4 Corrosions of multiple regions, unspecified degree	0.012	0.987	0.000
T29.2 Burns of multiple regions, no more than second-degree burns mentioned	0.012	0.987	0.000
T29.1 Burns of multiple regions, no more than first-degree burns mentioned	0.012	0.987	0.000
T29.0 Burns of multiple regions, unspecified degree	0.012	0.987	0.000
T30.7 Corrosion of third degree, body region unspecified	0.012	0.988	0.000
T30.6 Corrosion of second degree, body region unspecified	0.012	0.988	0.000
T30.5 Corrosion of first degree, body region unspecified	0.012	0.988	0.000
T30.4 Corrosion of unspecified body region, unspecified degree	0.012	0.988	0.000
T30.3 Burn of third degree, body region unspecified	0.012	0.988	0.000
T30.2 Burn of second degree, body region unspecified	0.012	0.988	0.000
T30.1 Burn of first degree, body region unspecified	0.012	0.988	0.000
T30.0 Burn of unspecified body region, unspecified degree	0.012	0.988	0.000
T32.9 Corrosions involving 90% or more of body surface	0.012	0.988	0.000
T32.8 Corrosions involving 80-89% of body surface	0.012	0.988	0.000
T32.7 Corrosions involving 70-79% of body surface	0.012	0.988	0.000
T32.6 Corrosions involving 60-69% of body surface	0.012	0.988	0.000
T32.5 Corrosions involving 50-59% of body surface	0.012	0.988	0.000
T32.4 Corrosions involving 40-49% of body surface	0.012	0.988	0.000
T32.3 Corrosions involving 30-39% of body surface	0.012	0.988	0.000
T32.2 Corrosions involving 20-29% of body surface	0.012	0.988	0.000
T32.1 Corrosions involving 10-19% of body surface	0.012	0.988	0.000
T32.0 Corrosions involving less than 10% of body surface	0.012	0.988	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.988	0.012
K72 Hepatic failure, not elsewhere classified	0.000	0.988	0.012
K72.0 Acute and subacute hepatic failure	0.000	0.988	0.012
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.000	0.989	0.011
U80 Agent resistant to penicillin and related antibiotics	0.000	0.989	0.011
I71 Aortic aneurysm and dissection	0.000	0.989	0.011
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.990	0.010
S69.9 Unspecified injury of wrist and hand	0.000	0.990	0.010
K75.0 Abscess of liver	0.000	0.990	0.010
K75.3 Granulomatous hepatitis, not elsewhere classified	0.000	0.990	0.010
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.990	0.010
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.990	0.010
K77 Liver disorders in diseases classified elsewhere	0.000	0.990	0.009
K75.2 Nonspecific reactive hepatitis	0.000	0.991	0.009
K75.1 Phlebitis of portal vein	0.000	0.991	0.009
J36 Peritonsillar abscess	0.009	0.991	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.991	0.009
K72.1 Chronic hepatic failure	0.000	0.991	0.009
I71.0 Dissection of aorta [any part]	0.000	0.991	0.009
K71 Toxic liver disease	0.000	0.991	0.008
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.992	0.008
U88 Agent resistant to multiple antibiotics	0.000	0.992	0.008
K75.4 Autoimmune hepatitis	0.000	0.992	0.008
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.992	0.008
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.992	0.008
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.992	0.008
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.992	0.008
M54.22 Cervicalgia (Cervical region)	0.000	0.992	0.008
U82-U85 Resistance to antimicrobial and antineoplastic drugs	0.000	0.992	0.008
K72.9 Hepatic failure, unspecified	0.000	0.993	0.007
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.993	0.007
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.993	0.007
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.993	0.007
Chapter XXII Codes for special purposes	0.000	0.993	0.007
M54.29 Cervicalgia-Site unspe	0.000	0.993	0.007
K73 Chronic hepatitis, not elsewhere classified	0.000	0.993	0.006
K71.9 Toxic liver disease, unspecified	0.000	0.994	0.006
K71.8 Toxic liver disease with other disorders of liver	0.000	0.994	0.006
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.994	0.006
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.994	0.006
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.994	0.006
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.994	0.006
K71.2 Toxic liver disease with acute hepatitis	0.000	0.994	0.006
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.994	0.006
I60 Subarachnoid haemorrhage	0.000	0.994	0.006
U50 Level of care administered to neonates	0.000	0.994	0.006
U07 Emergency use of U07	0.000	0.994	0.006
U06 Emergency use of U06	0.000	0.994	0.006
U04 Severe acute respiratory syndrome [SARS]	0.000	0.994	0.006
U52 First in a series of a regular day/night admissions	0.000	0.994	0.006
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.994	0.006
U89 Agent resistant to other and unspecified antibiotics	0.000	0.994	0.006
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.994	0.006
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.994	0.006
K71.0 Toxic liver disease with cholestasis	0.000	0.994	0.006
U51 Admission status on psychiatric patients	0.000	0.994	0.006
U84 Resistance to other antimicrobial drugs	0.000	0.994	0.006
U83 Resistance to other antibiotics	0.000	0.994	0.006
U82 Resistance to betalactam antibiotics	0.000	0.994	0.006
U85 Resistance to antineoplastic drugs	0.000	0.994	0.006
M54.2 Cervicalgia	0.000	0.994	0.006
K76.6 Portal hypertension	0.000	0.994	0.006
U80.0 Penicillin resistant agent	0.000	0.995	0.005
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.000	0.995	0.005
I60.9 Subarachnoid haemorrhage, unspecified	0.000	0.995	0.005
U89.8 Agent resistant to other single specified antibiotic	0.000	0.995	0.005
K75.8 Other specified inflammatory liver diseases	0.000	0.995	0.005
N71.9 Inflammatory disease of uterus, unspecified	0.005	0.995	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.000	0.995	0.005
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.995	0.005
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.995	0.005
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.995	0.005
E10.3 With ophthalmic complications	0.005	0.995	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.000	0.995	0.005
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.995	0.005
U06.9 Emergency use of U06.9	0.000	0.995	0.005
U06.8 Emergency use of U06.8	0.000	0.995	0.005
U06.7 Emergency use of U06.7	0.000	0.995	0.005
U06.6 Emergency use of U06.6	0.000	0.995	0.005
U06.5 Emergency use of U06.5	0.000	0.995	0.005
U06.4 Emergency use of U06.4	0.000	0.995	0.005
U06.3 Emergency use of U06.3	0.000	0.995	0.005
U06.2 Emergency use of U06.2	0.000	0.995	0.005
U06.1 Emergency use of U06.1	0.000	0.995	0.005
U06.0 Emergency use of U06.0	0.000	0.995	0.005
U07.9 Emergency use of U07.9	0.000	0.995	0.005
U07.8 Emergency use of U07.8	0.000	0.995	0.005
U07.7 Emergency use of U07.7	0.000	0.995	0.005
U07.6 Emergency use of U07.6	0.000	0.995	0.005
U07.5 Emergency use of U07.5	0.000	0.995	0.005
U07.4 Emergency use of U07.4	0.000	0.995	0.005
U07.3 Emergency use of U07.3	0.000	0.995	0.005
U07.2 Emergency use of U07.2	0.000	0.995	0.005
U07.1 Emergency use of U07.1	0.000	0.995	0.005
U07.0 Emergency use of U07.0	0.000	0.995	0.005
U50.9 Inquest Adjourned Death	0.000	0.995	0.005
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.995	0.005
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.995	0.005
U50.1 Level of care administered to neonates (Special Care)	0.000	0.995	0.005
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.995	0.005
U89.9 Agent resistant to unspecified antibiotic	0.000	0.995	0.005
E10.9 Without complications	0.005	0.995	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.995	0.005
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.995	0.005
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.995	0.005
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.995	0.005
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.995	0.005
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.995	0.005
T44.0 Anticholinesterase agents	0.000	0.995	0.005
E10 Insulin-dependent diabetes mellitus	0.005	0.995	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.000	0.995	0.005
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.995	0.004
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.000	0.995	0.005
I60.8 Other subarachnoid haemorrhage	0.000	0.995	0.005
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.995	0.004
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.995	0.004
U81.0 Vancomycin resistant agent	0.000	0.995	0.004
I60.4 Subarachnoid haemorrhage from basilar artery	0.000	0.995	0.004
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.995	0.004
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.996	0.004
U82.9 Resistance to betalactam antibiotics, unspecified	0.000	0.996	0.004
U82.8 Resistance to other betalactam antibiotics	0.000	0.996	0.004
U82.2 Extended spectrum betalactamase (ESBL) resistance	0.000	0.996	0.004
U82.1 Resistance to methicillin	0.000	0.996	0.004
U82.0 Resistance to penicillin	0.000	0.996	0.004
U83.9 Resistance to unspecified antibiotic	0.000	0.996	0.004
U83.8 Resistance to other single specified antibiotic	0.000	0.996	0.004
U83.7 Resistance to multiple antibiotics	0.000	0.996	0.004
U83.2 Resistance to quinolones	0.000	0.996	0.004
U83.1 Resistance to other vancomycin related antibiotics	0.000	0.996	0.004
U83.0 Resistance to vancomycin	0.000	0.996	0.004
U84.9 Resistance to unspecified antimicrobial drugs	0.000	0.996	0.004
U84.8 Resistance to other specified antimicrobial drug	0.000	0.996	0.004
U84.7 Resistance to multiple antimicrobial drugs	0.000	0.996	0.004
U84.3 Resistance to tuberculostatic drug(s)	0.000	0.996	0.004
U84.2 Resistance to antiviral drug(s)	0.000	0.996	0.004
U84.1 Resistance to antifungal drug(s)	0.000	0.996	0.004
U84.0 Resistance to antiparasitic drug(s)	0.000	0.996	0.004
M54.27 Cervicalgia-Lumbosacral	0.000	0.996	0.004
M54.26 Cervicalgia-Lumbar	0.000	0.996	0.004
M54.25 Cervicalgia-Thoracolumbar	0.000	0.996	0.004
M54.24 Cervicalgia-Thoracic	0.000	0.996	0.004
M54.21 Cervicalgia (Occipito-atlanto-axial region)	0.000	0.996	0.004
M54.20 Cervicalgia-Mult site	0.000	0.996	0.004
E10.5 With peripheral circulatory complications	0.004	0.996	0.000
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.000	0.996	0.004
K76 Other diseases of liver	0.000	0.996	0.004
E10.0 With coma	0.004	0.996	0.000
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.004	0.996	0.000
M54.28 Cervicalgia-Sacral/sacrococ	0.000	0.996	0.004
R47.8 Other and unspecified speech disturbances	0.000	0.996	0.004
E10.8 With unspecified complications	0.004	0.996	0.000
M54.23 Cervicalgia (Cervicothoracic region)	0.000	0.996	0.004
T84.1 Mechanical complication of internal fixation device of bones of limb	0.000	0.996	0.004
S69 Other and unspecified injuries of wrist and hand	0.000	0.996	0.004
D07.1 Vulva	0.004	0.996	0.000
T40.2 Other opioids	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
E10.7 With multiple complications	0.004	0.996	0.000
N32.9 Bladder disorder, unspecified	0.004	0.996	0.000
K73.9 Chronic hepatitis, unspecified	0.000	0.996	0.003
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.996	0.004
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
E10.4 With neurological complications	0.004	0.996	0.000
E10.2 With renal complications	0.003	0.996	0.000
E10.6 With other specified complications	0.003	0.996	0.000
D37.4 Colon	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.997	0.003
E10.1 With ketoacidosis	0.003	0.997	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.997	0.003
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
T40.4 Other synthetic narcotics	0.000	0.997	0.003
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
K76.1 Chronic passive congestion of liver	0.000	0.997	0.003
K76.5 Hepatic veno-occlusive disease	0.000	0.997	0.003
K76.4 Peliosis hepatis	0.000	0.997	0.003
K76.3 Infarction of liver	0.000	0.997	0.003
K76.2 Central haemorrhagic necrosis of liver	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
H44.0 Purulent endophthalmitis	0.003	0.997	0.000
M31.6 Other giant cell arteritis	0.003	0.997	0.000
D07.4 Penis	0.003	0.997	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.000	0.997	0.003
G37.9 Demyelinating disease of central nervous system, unspecified	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
S69.8 Other specified injuries of wrist and hand	0.000	0.997	0.003
D37.7 Other digestive organs	0.000	0.997	0.003
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.997	0.003
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
G37.8 Other specified demyelinating diseases of central nervous system	0.003	0.997	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.997	0.003
D07 Carcinoma in situ of other and unspecified genital organs	0.003	0.997	0.000
E04.1 Non-toxic single thyroid nodule	0.000	0.997	0.003
C17.9 Small intestine, unspecified	0.003	0.997	0.000
S69.7 Multiple injuries of wrist and hand	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.997	0.003
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.997	0.003
D37.5 Rectum	0.000	0.997	0.003
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.997	0.003
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
T47.7 Emetics	0.000	0.997	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.002
T47.5 Digestants	0.000	0.997	0.002
T47.4 Other laxatives	0.000	0.997	0.002
T47.3 Saline and osmotic laxatives	0.000	0.997	0.002
T47.2 Stimulant laxatives	0.000	0.997	0.002
D37.2 Small intestine	0.000	0.997	0.003
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.000	0.997	0.003
S70.9 Superficial injury of hip and thigh, unspecified	0.003	0.997	0.000
T45.0 Antiallergic and antiemetic drugs	0.000	0.997	0.003
D37.9 Digestive organ, unspecified	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.002
T45.4 Iron and its compounds	0.000	0.997	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.002
M77.02 Medial epicondylitis (Upper arm)	0.002	0.998	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
N13.1 Hydronephrosis with ureteral stricture, not elsewhere classified	0.000	0.998	0.002
X63.0 Home	0.000	0.998	0.002
G37 Other demyelinating diseases of central nervous system	0.002	0.998	0.000
K76.7 Hepatorenal syndrome	0.000	0.998	0.002
D37.3 Appendix	0.000	0.998	0.002
D25.9 Leiomyoma of uterus, unspecified	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
D07.6 Other and unspecified male genital organs	0.002	0.998	0.000
D07.5 Prostate	0.002	0.998	0.000
D07.3 Other and unspecified female genital organs	0.002	0.998	0.000
D07.0 Endometrium	0.002	0.998	0.000
D37.1 Stomach	0.000	0.998	0.002
D07.2 Vagina	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
O90 Complications of the puerperium, not elsewhere classified	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
H57.1 Ocular pain	0.002	0.998	0.000
M72.2 Plantar fascial fibromatosis	0.002	0.998	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
S62.51 Fracture of thumb (open)	0.002	0.998	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
B02.9 Zoster without complication	0.002	0.998	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
D37.6 Liver, gallbladder and bile ducts	0.000	0.998	0.002
O36.9 Maternal care for foetal problem, unspecified	0.000	0.998	0.002
O90.9 Complication of the puerperium, unspecified	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
H44.2 Degenerative myopia	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
D61.9 Aplastic anaemia, unspecified	0.000	0.998	0.002
T23.1 Burn of first degree of wrist and hand	0.002	0.998	0.000
G37.5 Concentric sclerosis [Balo]	0.002	0.998	0.000
G37.4 Subacute necrotising myelitis	0.002	0.998	0.000
G37.2 Central pontine myelinolysis	0.002	0.998	0.000
G37.1 Central demyelination of corpus callosum	0.002	0.998	0.000
G37.0 Diffuse sclerosis	0.002	0.998	0.000
H44 Disorders of globe	0.002	0.998	0.000
R47 Speech disturbances, not elsewhere classified	0.000	0.998	0.002
D37.0 Lip, oral cavity and pharynx	0.000	0.998	0.002
O90.0 Disruption of Caesarean section wound	0.000	0.998	0.002
D47.3 Essential (haemorrhagic) thrombocythaemia	0.000	0.998	0.002
K86.1 Other chronic pancreatitis	0.000	0.998	0.002
Z13.9 Special screening examination, unspecified	0.002	0.998	0.000
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system	0.002	0.998	0.000
O90.1 Disruption of perineal obstetric wound	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
C17.1 Jejunum	0.002	0.998	0.000
Z12.8 Special screening examination for neoplasm of other sites	0.000	0.998	0.002
T23 Burn and corrosion of wrist and hand	0.002	0.998	0.000
I85.0 Oesophageal varices with bleeding	0.000	0.998	0.002
O90.5 Postpartum thyroiditis	0.000	0.998	0.002
O90.4 Postpartum acute renal failure	0.000	0.998	0.002
O90.3 Cardiomyopathy in the puerperium	0.000	0.998	0.002
I74.5 Embolism and thrombosis of iliac artery	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
J14 Pneumonia due to Haemophilus influenzae	0.002	0.998	0.000
M72.29 Plantar fascial fibromatosis-Site unspec	0.002	0.998	0.000
M72.28 Plantar fascial fibromatosis-Other	0.002	0.998	0.000
M72.26 Plantar fascial fibromatosis-Lower Leg	0.002	0.998	0.000
M72.25 Plantar fascial fibromatosis-Pelvic/Thigh	0.002	0.998	0.000
M72.24 Plantar fascial fibromatosis-Hand	0.002	0.998	0.000
M72.23 Plantar fascial fibromatosis-Forearm	0.002	0.998	0.000
M72.22 Plantar fascial fibromatosis-Upper arm	0.002	0.998	0.000
M72.21 Plantar fascial fibromatosis-Shldr region	0.002	0.998	0.000
M72.20 Plantar fascial fibromatosis-Mult sites	0.002	0.998	0.000
H44.4 Hypotony of eye	0.002	0.998	0.000
C17 Malignant neoplasm of small intestine	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T22.0 Burn of unspecified degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
T23.2 Burn of second degree of wrist and hand	0.002	0.998	0.000
X68.9 Unspecified place	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.000	0.998	0.002
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.000	0.998	0.002
T22.3 Burn of third degree of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
Y60.0 During surgical operation	0.000	0.998	0.002
S82.81 Fractures of other parts of lower leg (open)	0.002	0.998	0.000
C17.0 Duodenum	0.002	0.998	0.000
T23.3 Burn of third degree of wrist and hand	0.002	0.998	0.000
L29.0 Pruritus ani	0.000	0.998	0.002
T22 Burn and corrosion of shoulder and upper limb, except wrist and hand	0.002	0.998	0.000
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg	0.000	0.998	0.002
H44.9 Disorder of globe, unspecified	0.002	0.998	0.000
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.002	0.998	0.000
H44.6 Retained (old) intraocular foreign body, magnetic	0.002	0.998	0.000
H44.5 Degenerated conditions of globe	0.002	0.998	0.000
H44.3 Other degenerative disorders of globe	0.002	0.998	0.000
S43.0 Dislocation of shoulder joint	0.000	0.998	0.002
S70.0 Contusion of hip	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
R82.7 Abnormal findings on microbiological examination of urine	0.002	0.998	0.000
Z04.3 Examination and observation following other accident	0.000	0.998	0.002
M31 Other necrotising vasculopathies	0.002	0.998	0.000
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.998	0.002
M31.5 Giant cell arteritis with polymyalgia rheumatica	0.002	0.998	0.000
T23.0 Burn of unspecified degree of wrist and hand	0.002	0.998	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.000	0.998	0.002
R47.0 Dysphasia and aphasia	0.000	0.998	0.002
T23.7 Corrosion of third degree of wrist and hand	0.001	0.998	0.000
T23.6 Corrosion of second degree of wrist and hand	0.001	0.998	0.000
T23.5 Corrosion of first degree of wrist and hand	0.001	0.998	0.000
T23.4 Corrosion of unspecified degree of wrist and hand	0.001	0.998	0.000
O90.2 Haematoma of obstetric wound	0.000	0.998	0.001
S70 Superficial injury of hip and thigh	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.002
H44.1 Other endophthalmitis	0.001	0.998	0.000
M31.1 Thrombotic microangiopathy	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
M80.99 Unspecified osteoporosis with pathological fracture (Site unspecified)	0.000	0.998	0.002
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
C17.8 Overlapping lesion of small intestine	0.001	0.998	0.000
C17.3 Meckel's diverticulum	0.001	0.998	0.000
M80.9 Unspecified osteoporosis with pathological fracture	0.000	0.998	0.002
S70.8 Other superficial injuries of hip and thigh	0.002	0.998	0.000
X10.0 Home	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.001	0.998	0.000
Y42.4 Oral contraceptives	0.001	0.998	0.000
N71 Inflammatory disease of uterus, except cervix	0.002	0.998	0.000
I74 Arterial embolism and thrombosis	0.000	0.998	0.002
N41.9 Inflammatory disease of prostate, unspecified	0.000	0.998	0.002
X63.9 Unspecified place	0.000	0.998	0.001
X63.8 Other specified place	0.000	0.998	0.001
X63.7 Farm	0.000	0.998	0.001
X63.6 Industrial and construction area	0.000	0.998	0.001
X63.5 Trade and service area	0.000	0.998	0.001
X63.4 Street and highway	0.000	0.998	0.001
X63.3 Sports and athletics area	0.000	0.998	0.001
X63.2 School, other institution and public administrative area	0.000	0.998	0.001
X63.1 Residential institution	0.000	0.998	0.001
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
G93.4 Encephalopathy, unspecified	0.002	0.998	0.000
H44.8 Other disorders of globe	0.001	0.998	0.000
M31.0 Hypersensitivity angiitis	0.001	0.998	0.000
E13.9 Without complications	0.001	0.998	0.000
R47.1 Dysarthria and anarthria	0.000	0.998	0.001
M80.90 Unspecified osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.001
B02.1 Zoster meningitis	0.001	0.998	0.000
C17.2 Ileum	0.001	0.998	0.000
T22.7 Corrosion of third degree of shoulder and upper limb, except wrist and hand	0.001	0.998	0.000
T22.6 Corrosion of second degree of shoulder and upper limb, except wrist and hand	0.001	0.998	0.000
T22.5 Corrosion of first degree of shoulder and upper limb, except wrist and hand	0.001	0.998	0.000
T22.4 Corrosion of unspecified degree of shoulder and upper limb, except wrist and hand	0.001	0.998	0.000
T22.1 Burn of first degree of shoulder and upper limb, except wrist and hand	0.001	0.998	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.000	0.998	0.001
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.000	0.998	0.001
M31.7 Microscopic polyangiitis	0.001	0.998	0.000
M31.4 Aortic arch syndrome [Takayasu]	0.001	0.998	0.000
Y42.5 Other oestrogens and progestogens	0.001	0.998	0.000
Z96.2 Presence of otological and audiological implants	0.001	0.998	0.000
X68 Intentional self-poisoning by and exposure to pesticides	0.000	0.998	0.001
M31.9 Necrotising vasculopathy, unspecified	0.001	0.999	0.000
M31.8 Other specified necrotising vasculopathies	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations